Showing results (261-270 of 753) with videos related to
Sort By:
Pageof 76
Journal of Neurosurgery|July 21, 2005
The Ki-67 labeling index as a prognostic factor in Grade II oligoastrocytomasMark E Shaffrey, Elana Farace, David Schiff, et al.The Lancet. Oncology|February 3, 2007
Part II: spinal-cord neoplasms--primary tumours of the bony spine and adjacent soft tissuesCharles A Sansur, Nader Pouratian, Aaron S Dumont, et al.Neuro-Oncology|January 10, 2015
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic gliomaEudocia Q Lee, David A Reardon, David Schiff, et al.Neuro-Oncology|September 22, 2016
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trialsEdward K Avila, Marc Chamberlain, David Schiff, et al.JCO Precision Oncology|September 11, 2020
Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With GlioblastomaBrian M Alexander, Lorenzo Trippa, Sarah Gaffey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium StudyTimothy F Cloughesy, Patrick Y Wen, H Ian Robins, et al.Journal of Neuro-Oncology|October 13, 2006
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiformeMorris D Groves, Vinay K Puduvalli, Susan M Chang, et al.Journal of Neuro-Oncology|May 6, 2014
Spin-echo echo-planar perfusion prior to chemoradiation is a strong independent predictor of progression-free and overall survival in newly diagnosed glioblastomaAyca Akgoz, Rifaquat Rahman, Hui You, et al.Expert Opinion on Emerging Drugs|May 15, 2013
Update on bevacizumab and other angiogenesis inhibitors for brain cancerMikael L Rinne, Eudocia Q Lee, Lakshmi Nayak, et al.Neuro-Oncology|February 8, 2025
Identifying appropriate external control datasets in support of future glioblastoma clinical trials leveraging external dataRifaquat Rahman, Steffen Ventz, Robert Redd, et al.Pageof 76